Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
מצבים רפואיים
Advanced Non-squamous Non-small-cell Lung Cancer · Advanced Squamous Non-Small Cell Lung Carcinoma · Metastatic Non-squamous Non Small Cell Lung Cancer · Metastatic Squamous Non-Small Cell Lung Carcinoma · Non-small Cell Lung Cancer · Non-small Cell Lung Cancer Stage III · Non-small Cell Lung Cancer Stage IV · Non-small Cell Lung Cancer Recurrent
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Pioneer Research Center, LLC, Bullhead City, Arizona, United States
Contact: Principal Investigator (Hamdy Mohtaseb, MD)Clermont Oncology Center, Clermont, Florida, United States
Contact: Principal Investigator (Gopal Kunta, MD)Oncology & Hematology Associates of West Broward, Coral Springs, Florida, United States
Contact: Principal Investigator (Sumit Sawhney, MD)Helios Clinical Research, Fort Lauderdale, Florida, United States
Contact: Study coordinator (Kylee Charlemagne) · kylee.charlemagne@heliosclinical.com · 645-225-9003Contact: Principal Investigator (Edgardo Santos, MD)Bioresearch Partner, Hialeah, Florida, United States
Contact: Principal Investigator (Luis Rangel, MD)University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Contact: Principal Investigator (Richa Dawar, MD)Bioresearch Partner, Miami, Florida, United States
Contact: Principal Investigator (Javier Perez Fernandez, MD)Mid Florida Hematology and Oncology Center, Orange City, Florida, United States
Contact: Principal Investigator (Santosh Nair, MD)BRCR Medical Center, Inc., Plantation, Florida, United States
Contact: Principal Investigator (Harshad Amin, MD)Michigan Hematology and Oncology Consultants, Dearborn, Michigan, United States
Contact: Principal Investigator (Faisel Musa, MD)Oakland Medical Group, Farmington Hills, Michigan, United States
Contact: Study coordinator (Catherine Maples) · Catherine.Maples@profoundresearch.com · 517-375-3057Contact: Principal Investigator (Jeffrey Margolis, MD)Inspira Medical Center Mullica Hill, Mullica Hill, New Jersey, United States
Contact: Principal Investigator (Erev Tubb, MD)Gabrail Cancer and Research Center, Canton, Ohio, United States
Contact: Principal Investigator (Nashat Gabrail, MD)Texas Oncology - Austin Central, Austin, Texas, United States
Contact: Principal Investigator (James Uyeki, MD)World Research Link, Baytown, Texas, United States
Contact: Study coordinator (Isabel Navarrete) · isabel.navarrete@worldresearchlink.com · 833-832-8328Contact: Principal Investigator (Amir Rasheed, MD)